ICD-10-CM code · FY2027
E26.02 Glucocorticoid-remediable aldosteronism
BillableValid for claims as a specific diagnosis code
About E26.02
EvidencePulse™by 2 Minute Medicine®
Go deeper into hyperaldosteronism.
Ask about the latest evidence, the landmark trials or what guidelines recommend, with every study cited. No ads, no sponsored answers.
Coding notes for E26.02
Applicable to Other names for conditions reported with this code.
- Familial aldosteronism type I
Block E20-E35 notes (apply to every code in it)
Chapter 4 notes (apply to every code in it)
Note
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Related codes in E26.0
- E26.01 Conn's syndromeBillable
- E26.09 Other primary hyperaldosteronismBillable
2MM+
Read the research behind every diagnosis
2MM+ gives you every study summary in full, Classics downloads of the landmark trials, EvidencePulse and HypeCheck, and ad-free reading.
See 2MM+ plansICD-10-CM FY2027 code set, as published by the CDC National Center for Health Statistics (NCHS) and CMS, effective October 1, 2026 to September 30, 2027. Codes, titles and notes are shown as published. Check payer rules and the official guidelines before billing. This page is not medical advice.
Get the app